Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2025-12-24 @ 10:50 PM
NCT ID:
NCT00698269
Eligibility Criteria:
Inclusion Criteria:
* Type 1 or type 2 diabetes
* Treatment with any diabetes treatment other than NovoMix® 30, Levemir® and/or NovoRapid®
* Selection will be at the discretion of the individual physician
Exclusion Criteria:
* Current treatment with Levemir®, NovoMix® 30 and/or NovoRapid®
* Previous enrolled in this study
* Hypersensitivity to Levemir®, NovoMix® 30 and/or NovoRapid® or to any of the excipients
* Women who are pregnant, breast feeding or have the intention of becoming pregnant within next 6 months
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00698269
Study Brief:
Protocol Section:
NCT00698269